Literature DB >> 7824836

Psychiatric symptoms before systemic lupus erythematosus is diagnosed.

A P van Dam1, E M Wekking, J A Callewaert, A J Schipperijn, H A Oomen, J de Jong, A J Swaak, R J Smeenk, T E Feltkamp.   

Abstract

Psychiatric symptoms are rarely reported as an initial feature of systemic lupus erythematosus (SLE). Nevertheless, many patients have the feeling that psychiatric symptoms occurred before they were diagnosed as having SLE. This feeling was confirmed by an enquiry among members of the Dutch Lupus Patients Society: half of them had experienced psychiatric complaints before SLE was diagnosed. Two-thirds of these patients searched for professional help for these complaints. This motivated us to study whether SLE patients were admitted into psychiatric hospitals without being diagnosed as having SLE. Sera from 2121 patients admitted to a psychiatric hospital and from 500 controls matched for sex and age were tested for the presence of antinuclear antibodies (ANA) and antibodies to DNA. ANA were found in 3% of patients, as well as controls. Anti-DNA antibodies were found in 1% of both patients and controls. Two out of 114 patients psychiatric patients with ANA and/or anti-DNA antibodies had SLE and/or Sjögren's syndrome. We concluded that SLE is not an important cause of admission to psychiatric hospitals. Routine tests for the determination of antinuclear and anti-DNA antibodies on admissions in these hospitals thus would not seem useful. To study whether patients with another chronic disease also had psychiatric complaints before being diagnosed, we performed the same enquiry among members of the Dutch Sarcoidosis Patients Society. The results were almost equal to those of the enquiry of the members of the Dutch Lupus Patients Society. Why members of both societies so often report psychiatric symptoms before their disease is diagnosed should be a subject of further studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824836     DOI: 10.1007/bf00300248

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

1.  A simple indirect LE-cell test with increased sensitivity.

Authors:  J H KIEVITS; H R SCHUIT
Journal:  Vox Sang       Date:  1957-09       Impact factor: 2.144

2.  Antinuclear factor in psychiatric disorders.

Authors:  H von Brauchitsch
Journal:  Am J Psychiatry       Date:  1972-06       Impact factor: 18.112

3.  Systemic lupus erythematosus induced by psychotropic drugs.

Authors:  A J Fabius; W K Gaulhofer
Journal:  Acta Rheumatol Scand       Date:  1971

Review 4.  Neurosarcoidosis: signs, course and treatment in 35 confirmed cases.

Authors:  C Chapelon; J M Ziza; J C Piette; Y Levy; G Raguin; B Wechsler; M O Bitker; O Blétry; D Laplane; M G Bousser
Journal:  Medicine (Baltimore)       Date:  1990-09       Impact factor: 1.889

5.  Low avidity antibodies to dsDNA as a diagnostic tool.

Authors:  J C Nossent; V Huysen; R J Smeenk; A J Swaak
Journal:  Ann Rheum Dis       Date:  1989-09       Impact factor: 19.103

6.  Antibodies to histones in drug-induced and idiopathic lupus erythematosus.

Authors:  M J Fritzler; E M Tan
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

7.  Anorexia nervosa in a patient with systemic lupus erythematosus.

Authors:  P Bambery; S Malhotra; U Kaur; R Chadda; S D Deodhar
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

8.  Psychiatric problems in systemic lupus erythematosus.

Authors:  A MacNeill; D M Grennan; D Ward; W C Dick
Journal:  Br J Psychiatry       Date:  1976-05       Impact factor: 9.319

9.  Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment.

Authors:  E C Johnstone; K Whaley
Journal:  Br Med J       Date:  1975-06-28

10.  Avidity of antibodies to dsDNA: comparison of IFT on Crithidia luciliae, Farr assay, and PEG assay.

Authors:  R Smeenk; G van der Lelij; L Aarden
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

View more
  6 in total

1.  Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice.

Authors:  Kelly K Anderson; David A Ballok; Neena Prasad; Henry Szechtman; Boris Sakic
Journal:  Behav Brain Res       Date:  2005-09-23       Impact factor: 3.332

2.  Behavioral heterogeneity in an animal model of neuropsychiatric lupus.

Authors:  Boris Sakic; Steven E Hanna; Jason M Millward
Journal:  Biol Psychiatry       Date:  2005-03-15       Impact factor: 13.382

Review 3.  Challenges of Diagnosing Cognitive Dysfunction With Neuropsychiatric Systemic Lupus Erythematosus in Childhood.

Authors:  Ashwaq AlE'ed; Patricia Vega-Fernandez; Eyal Muscal; Claas H Hinze; Lori B Tucker; Simone Appenzeller; Brigitte Bader-Meunier; Johannes Roth; Vicenç Torrente-Segarra; Marisa S Klein-Gitelman; Deborah M Levy; Tresa Roebuck-Spencer; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08-29       Impact factor: 4.794

4.  Purine receptor antagonist modulates serology and affective behaviors in lupus-prone mice: evidence of autoimmune-induced pain?

Authors:  David A Ballok; Boris Sakic
Journal:  Brain Behav Immun       Date:  2008-06-14       Impact factor: 7.217

5.  Schizophrenia or Atypical Lupus Erythematosus with Predominant Psychiatric Manifestations over 25 Years: Case Analysis and Review.

Authors:  Axel Mack; Christiane Pfeiffer; E Marion Schneider; Karl Bechter
Journal:  Front Psychiatry       Date:  2017-07-27       Impact factor: 4.157

6.  The introspection on the diagnosis and treatment process of a case of Guillain-Barré syndrome (GBS) attributed to systemic lupus erythematosus (SLE): A case report.

Authors:  Nan Zhang; Jie Cao; Meng Zhao; Li Sun
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.